| GC30099-50mg |
|
150810-68-7 |
5-TAMRA-SE (5-TAMRA-NHS ester)
|
0 |
C29H25N3O7 |
|
|
|
| GC30099-10mg |
|
150810-68-7 |
5-TAMRA-SE (5-TAMRA-NHS ester)
|
0 |
C29H25N3O7 |
|
|
|
| GC30099-5mg |
|
150810-68-7 |
5-TAMRA-SE (5-TAMRA-NHS ester)
|
0 |
C29H25N3O7 |
|
|
|
| GC30099-1mg |
|
150810-68-7 |
5-TAMRA-SE (5-TAMRA-NHS ester)
|
0 |
C29H25N3O7 |
|
|
|
| GC30099-10mM(1mLinDMSO) |
|
150810-68-7 |
5-TAMRA-SE (5-TAMRA-NHS ester)
|
0 |
C29H25N3O7 |
|
|
|
| GC30098-50mg |
|
1241390-29-3 |
|
0 |
C12H10F2N2O2 |
|
|
|
| GC30098-10mg |
|
1241390-29-3 |
|
0 |
C12H10F2N2O2 |
|
|
|
| GC30097-10mg |
|
220201-34-3 |
Talaporfin sodium (ME2906)
|
0 |
C38H37N5Na4O9 |
|
|
|
| GC30097-5mg |
|
220201-34-3 |
Talaporfin sodium (ME2906)
|
0 |
C38H37N5Na4O9 |
|
|
|
| GC30096-50mg |
|
1315323-00-2 |
|
0 |
C18H13F6N3O2S |
|
|
|
| GC30096-10mg |
|
1315323-00-2 |
|
0 |
C18H13F6N3O2S |
|
|
|
| GC30096-5mg |
|
1315323-00-2 |
|
0 |
C18H13F6N3O2S |
|
|
|
| GC30096-10mM(1mLinDMSO) |
|
1315323-00-2 |
|
0 |
C18H13F6N3O2S |
|
|
|
| GC30095-10mg |
|
351490-27-2 |
|
0 |
C26H32N2O4 |
|
|
|
| GC30095-5mg |
|
351490-27-2 |
|
0 |
C26H32N2O4 |
|
|
|
| GC30095-1mg |
|
351490-27-2 |
|
0 |
C26H32N2O4 |
|
|
|
| GC30094-5g |
|
2492-87-7 |
PNPG (4-Nitrophenyl β-D-glucopyranoside)
|
0 |
C12H15NO8 |
|
|
|
| GC30094-1g |
|
2492-87-7 |
PNPG (4-Nitrophenyl β-D-glucopyranoside)
|
0 |
C12H15NO8 |
|
|
|
| GC30094-10mM(1mLinDMSO) |
|
2492-87-7 |
PNPG (4-Nitrophenyl β-D-glucopyranoside)
|
0 |
C12H15NO8 |
|
|
|
| GC30093-100mg |
|
114311-32-9 |
|
0 |
C15H19N3O4 |
|
|
|
